Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

IGCIGC
21 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in IGC PHARMA INC

CITADEL ADVISORS LLC holds 437,317 shares of IGC (IGC PHARMA INC), worth $118,950 as of 2026-Q2. This is a new position.

Current Value

$118,950

Current Shares

437,317

Total Value Change

+$53,950

Total Shares Change

+397,738

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
437,317
-
$118,9500.0%$0.27
34
2026-Q1
Exited
0
-100.0%
$00.0%$0.29
0
2025-Q4
Decreased
277,594
-55.8%
$78,1150.0%$0.28
0
2025-Q3
Increased
627,840
+131.7%
$261,7460.0%$0.42
25
2025-Q2
Increased
270,966
+186.8%
$82,9160.0%$0.31
24
2025-Q1
Increased
94,471
+2979.2%
$26,9240.0%$0.29
21
2024-Q4
New
3,068
-
$1,0310.0%$0.35
17
2022-Q4
Exited
0
-100.0%
$00.0%$0.32
0
2022-Q3
Decreased
15,583
-87.9%
$7,0000.0%$0.46
0
2022-Q2
Increased
129,190
+1191.0%
$69,0000.0%$0.54
23
2022-Q1
Decreased
10,007
-82.4%
$10,0000.0%$1.00
0
2021-Q4
Decreased
56,796
-10.7%
$55,0000.0%$0.99
0
2021-Q3
Decreased
63,619
-18.1%
$94,0000.0%$1.48
0
2021-Q2
Increased
77,636
+404.8%
$127,0000.0%$1.56
24
2021-Q1
New
15,381
-
$28,0000.0%$1.70
30
2020-Q3
Exited
0
-100.0%
$00.0%$1.09
0
2020-Q2
New
29,459
-
$18,0000.0%$0.73
28
2020-Q1
Exited
0
-100.0%
$00.0%$0.56
0
2019-Q4
Decreased
14,735
-65.1%
$9,0000.0%$0.61
0
2019-Q3
Increased
42,231
+6.7%
$41,0000.0%$1.04
15
2019-Q2
New
39,579
-
$65,0000.0%$1.64
32

Other major holders of IGC: Mirae Asset Global Investments Co., Ltd., SUSQUEHANNA INTERNATIONAL GROUP, LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used